Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

AI Summary
Stanford University is utilizing 37,000 AI agents to function as a virtual biotech, with one of its drug designs receiving independent confirmation from Merck. James Zou emphasized that the future of AI development will focus on the collaboration of numerous agents rather than on creating a single, more advanced model.
From the source
For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about to break: the next frontier isn't a single, more capable agent, it's tens of thousands of them collaborating. For developers and product builders, the most critical takeaway from Zou’s presentation is how these massive systems are orchestrated. Hi
The full text couldn't be loaded here (the source may require a subscription).
View original at VentureBeat AI